4//SEC Filing
Jacques Rachelle Suzanne 4
Accession 0000950170-24-050854
CIK 0001541157other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 9:45 PM ET
Size
5.1 KB
Accession
0000950170-24-050854
Insider Transaction Report
Form 4
Jacques Rachelle Suzanne
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares, par value $0.0001 per share
2024-04-26+479,569,892→ 1,018,027,792 total
Footnotes (1)
- [F1]These shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive one ordinary share, par value $0.0001. 50% of the RSUs shall vest on March 28, 2025, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Documents
Issuer
Akari Therapeutics Plc
CIK 0001541157
Entity typeother
Related Parties
1- filerCIK 0001772610
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 9:45 PM ET
- Size
- 5.1 KB